Insights on the 3D Printed Drugs Market to 2027 - Featuring Tvasta, FabRx LTD, Cycle Pharmaceuticals Among Others

According to The Insight Partners market research study titled “3D Printed Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Dosage Forms and Technology,” the global 3D printed drugs market is expected to reach US$ 57.03 Mn in 2027 from US$ 28.52 Mn in 2019. The market is estimated to grow at a CAGR of 9.1% from 2020 to 2027.

Leading companies operating in the 3D printed drugs market are Aprecia Pharmaceuticals, LLC, FabRx Ltd, Cycle Pharmaceuticals, GlaxoSmithKline PLC., Astrazeneca, Tvasta, and Merck KGGA, among others.

Download PDF Sample of 300 Pages Research Report with Insights @ https://www.theinsightpartners.com/sample/TIPRE00010199/?utm_source=opr%2F10291

Key Benefits:

- 3D printed drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.

- The main idea behind 3D printing drugs is to design and develop medicines that are suited to an individual's needs.The global 3D printed drugs market is driven by factors such asincreasing adoption of personalized drugs.

- Additionally, growing research and development activities,coupled with increasing prevalence of dysphagia,is also anticipated to drive the 3D market growth during the forecast period.

COVID-19 Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Dry 3D Printed Drugs Market @ https://www.theinsightpartners.com/sample/TIPRE00010199/?utm_source=opr%2F10291

The COVID-19 pandemic is perplexing healthcare institutions in North America with unprecedented operational and clinical challenges. North American countries such as the US, Canada, and Mexico was totally closed for two to three months as the strict lockdown was imposed. The lockdown situation has resulted in a fall down a visit to healthcare facilities centers, and fewer prescriptions have been issued for ophthalmic conditions.

Market Insights

Dosage Form-BasedInsights- Based on dosage form, the 3D printed drugs market is segmented into tablets, capsules, multi drug implants, nanoparticles, solutions, and other dosage forms.

Technology-BasedInsights- Based on technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE).

Strategic Insights- Product launches and FDA approvalsis a commonly adopted strategy by companies to expand their footprint worldwide and meet the growing demand as the strategy allows them to expand their product portfolios.

Segmentation:

3D Printed Drugs Market – By Dosage Forms

Tablets
Capsules
Multi Drug Implants
Nanoparticles
Solutions
Others

3D Printed Drugs Market – By Technology

Inkjet Printing
Direct Write
Zip Dose
Thermal Inkjet Printing
Fused Deposition Modeling
Powder Bed Printing
Stereolithography (SLA)
Semi Solid Extrusion (SSE)

For Purchase this Report with Discount @ https://www.theinsightpartners.com/buy/TIPRE00010199/?utm_source=opr%2F10291

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.